Overview

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

Status:
Withdrawn

Trial end date:
2016-06-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine local skin safety of a topical analgesic spray containing a combination of diclofenac, methyl salicylate, menthol and compare it with a topical analgesic gel containing a combination of diclofenac, methyl salicylate, and menthol.

Phase:

Phase 4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Diclofenac
Menthol
Methyl salicylate
Salicylates
Salicylic Acid